Abnormal 5-HT1D receptor function in cluster headache: A neuroendocrine study with sumatriptan

Cephalalgia

Volumn 23, Issue 5, 2003, Pages 354-360

  Pinessi, Lorenzo ^a   Rainero, I ^a   Valfre W ^a   Lo Giudice, R ^a   Ferrero, M ^a   Rivoiro, C ^a   Arvat, E ^b   Gianotti, L ^b   Del Rizzo, P ^b   Limone, P ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

5 HT1D receptors; Cluster headache; Growth hormone; Prolactin; Sumatriptan

Indexed keywords

CORTICOTROPIN; GROWTH HORMONE; HYDROCORTISONE; PLACEBO; PROLACTIN; SEROTONIN 1D AGONIST; SEROTONIN 1D RECEPTOR; SUMATRIPTAN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLUSTER HEADACHE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; FEMALE; GROWTH HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; HYDROCORTISONE BLOOD LEVEL; IN VIVO STUDY; MALE; NEUROENDOCRINE SYSTEM; PROLACTIN BLOOD LEVEL; PROTEIN FUNCTION; REMISSION; SEROTONINERGIC SYSTEM; SIDE EFFECT; VERTIGO; ANALYSIS OF VARIANCE; BLOOD; COMPARATIVE STUDY; DOUBLE BLIND PROCEDURE; DRUG POTENTIATION; METABOLISM; MIDDLE AGED; NEUROSECRETION; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; ANALYSIS OF VARIANCE; CLUSTER HEADACHE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROSECRETORY SYSTEMS; RECEPTOR, SEROTONIN, 5-HT1D; STATISTICS, NONPARAMETRIC; SUMATRIPTAN;

EID: 0037833456     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.2003.00545.x     Document Type: Article

References (35)

1. Aurora SK. Etiology and pathogenesis of cluster headache. Curr Pain Headache Rep 2002; 6:71-5.
2. Pringsheim T. Cluster headache: evidence for a disorder of circadian rhythm and hypothalamic function. Can J Neurol Sci 2002; 29:33-40.
3. Dodick DW, Rozen TD, Goadsby PJ, Silberstein SD. Cluster headache. Cephalalgia 2000; 20:787-803.
4. Waldenlind E, Gustafsson SA. Prolactin in cluster headache: diurnal secretion, response to thyrotropin-releasing hormone, and relation to sex steroids and gonadotropins. Cephalalgia 1987; 7:43-54.
5. Leone M, Bussone G. A review of hormonal findings in cluster headache. Evidence for hypothalamic involvement. Cephalalgia 1993; 13:307-9.
6. Leone M, Lucini V, D'Amico D, Moschiano F, Maltempo C, Fraschini F et al. Twenty-four-hour melatonin and cortisol plasma levels in relation to timing of cluster headache. Cephalalgia 1995; 15:224-9.
7. May A, Bahra A, Buchel C, Frackowiak RS, Goadsby PJ. Hypothalamic activation in cluster headache attacks. Lancet 1998; 352:275-8.
8. May A, Ashburner J, Buchel C, McGonigle DJ, Friston KJ, Frackowiak RS et al. Correlation between structural and functional changes in brain in an idiopathic headache syndrome. Nat Med 1999; 5:836-8.
9. Gordon ML, Lipton RB, Brown SL, van Praag HM. The neuroendocrine challenge paradigm in headache research. Cephalalgia 1995; 15:292-6.
10. Leone M, Attanasio A, Croci D, Libro G, Grazzi L, D'Amico D et al. The m-chlorophenylpiperazine test in cluster headache: a study on central serotoninergic activity. Cephalalgia 1997; 17:666-72.
11. Gijsman HJ, Van Gerven JM, Tieleman MC, Schoemaker RC, Pieters MS, Ferrari MD et al. Pharmacokinetic and pharmacodynamic profile of oral and intravenous metachlorophenylpiperazine in healthy volunteers. J Clin Phychopharmacol 1998; 18:289-95.
12. Gobel H, Lindner V, Heinze A, Ribbat M, Deuschl G. Acute therapy for cluster headache with sumatriptan: findings of a one-year long-term study. Neurology 1998; 51:908-11.
13. Franceschini R, Cataldi A, Garibaldi A, Cianciosi P, Scordamaglia A, Barreca T et al. The effects of sumatriptan on pituitary secretion in man. Neuropharmacology 1994; 33:235-9.
14. Boeles S, Williams C, Campling GM, Goodall EM, Cowen PJ. Sumatriptan decreases food intake and increases plasma growth hormone in healthy women. Psychopharmacology 1997; 129:179-82.
15. Entwisle SJ, Fowler PA, Thomas M, Eckland DJ, Lettis S, York M et al. The effects of oral sumatriptan, a 5-HT1 receptor agonist, on circulating ACTH and cortisol concentrations in man. Br J Clin Pharmacol 1995; 39:389-95.
16. Valverde I, Penalva A, Dieguez C. Influence of different serotonin receptor subtypes on growth hormone secretion. Neuroendocrinology 2000; 71:145-53.
17. Ganong WF. Circumventricular organs: definition and role in the regulation of endocrine and autonomic function. Clin Exp Pharmacol Physiol 2000; 27:422-7.
18. Yatham LN, Zis AP, Lam RW, Tam E, Shiah IS. Sumatriptan-induced growth hormone release in patients with major depression, mania and normal controls. Neuropsychopharmacology 1997; 17:258-63.
19. 1D receptor function in major depression: a neuropharmacological challenge study using sumatriptan. Psychol Med 1998; 28:295-300.
20. Volpi R, Caffarra R, Scaglioni A, Boni S, Saginario A, Chidera P et al. Defective 5-HT1-receptor-mediated neurotransmission in the control of growth hormone secretion in Parkinson's disease. Neuropsychobiology 1997; 35:79-83.
21. Pinessi L, Rainero I, Savi L, Valfrè W, Limone P, Calvelli P et al. Effects of subcutaneous sumatriptan on plasma growth hormone concentrations in migraine patients. Cephalalgia 2000; 20:223-7.
22. Rainero I, Valfre W, Savi L, Gentile S, Pinessi L, Gianotti L et al. Neuroendocrine effects of subcutaneous sumatriptan in patients with migraine. J Endocrinol Invest 2001; 24:310-4.
23. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgia and facial pain. Cephalalgia 1988; 8 (Suppl. 7):1-96.
24. Spielbeger CD, Gorsuch RL, Luschene RE. State-trait anxiety inventory. Palo Alto: Consulting Psychologists Press, 1970.
25. Beck AT, Steer RA. BDI: Beck depression inventory manual. San Antonio: The Psychological Corporation, 1987.
26. Bussone G, Frediani F, Leone M, Grazzi L, Lamperti E, Boiardi A. TRH test in cluster headache. Headache 1988; 28:462-4.
27. Leone M, Zappacosta BM, Valentini S, Colangelo AM, Bussone G. The insulin tolerance test and the ovine corticotrophin-releasing hormone test in episodic cluster headache. Cephalalgia 1991; 11:269-74.
28. Leone M, Maltempo C, Gritti A, Bussone G. The insulin tolerance test and ovine corticotrophin-releasing-hormone test in episodic cluster headache. II. Comparison with low back pain patients. Cephalalgia 1994; 14:357-64.
29. Messing RB, Lytle LD. Serotonin-containing neurons: their possible role in pain and analgesia. Pain 1977; 4:1-21.
30. Wang QP, Nakai Y. The dorsal raphe: an important nucleus in pain modulation. Brain Res Bull 1994; 34:575-85.
31. Gear RW, Levine JD. Antinociception produced by an ascending spino-supraspinal pathway. J Neurosci 1995; 15:3154-61.
32. Eide PK, Hole K. The role of 5-hydroxytryptamine (5-HT) receptor subtypes and plasticity in the 5-HT systems in the regulation of nociceptive sensitivity. Cephalalgia 1993; 13:75-85.
33. Bono G, Antonaci F, Sandrini G, Pucci E, Rossi F, Nappi G. Pain pressure threshold in cluster headache patients. Cephalalgia 1996; 16:62-6.
34. Price LH, Charney DS, Delgado PL, Heninger GR. Lithium and serotonin function: implications for the serotonin hypothesis of depression. Psychopharmacology 1990; 100:3-12.
35. Sharp T, Bramwell SR, Lambert P, Grahame-Smith DG. Effect of short- and long-term administration of lithium on the release of endogenous 5-HT in the hippocampus of the rat in vivo and in vitro. Neuropharmacology 1991; 30:977-84.